Literature DB >> 22488895

No associations found between the genes situated at 6p22.1, HIST1H2BJ, PRSS16, and PGBD1 in Japanese patients diagnosed with schizophrenia.

Maiko Kitazawa1, Tohru Ohnuma, Yuto Takebayashi, Nobuto Shibata, Hajime Baba, Kazutaka Ohi, Yuka Yasuda, Yukako Nakamura, Branko Aleksic, Akira Yoshimi, Tomo Okochi, Masashi Ikeda, Hiroshi Naitoh, Ryota Hashimoto, Nakao Iwata, Norio Ozaki, Masatoshi Takeda, Heii Arai.   

Abstract

Recent GWAS demonstrated an association between candidate genes located at region 6p22.1 and schizophrenia. This region has been reported to house certain candidate SNPs, which may be associated with schizophrenia at HIST1H2BJ, PRSS16, and PGBD1. These genes may presumably be associated with pathophysiology in schizophrenia, namely epigenetics and psychoneuroimmunology. A three-step study was undertaken to focus on these genes with the following aims: (1) whether these genes may be associated in Japanese patients with schizophrenia by performing a 1st stage case-control study (514 cases and 706 controls) using Japanese tagging SNPs; (2) if the genetic regions of interest for the disease from the 1st stage of analyses were found, re-sequencing was performed to search for new mutations; (3) finally, a replication study was undertaken to confirm positive findings from the 1st stage were reconfirmed using a larger number of subjects (2,583 cases and 2,903 controls) during a 2nd stage multicenter replication study in Japan. Genotyping was performed using TaqMan PCR method for the selected nine tagging SNPs. Although three SNPs situated at the 3' side of PGBD1; rs3800324, rs3800327, and rs2142730, and two-window haplotypes between rs3800327 and rs2142730 showed positive associations with schizophrenia, these associations did not have enough power to sustain significance during the 2nd stage replication study. In addition, re-sequencing for exons 5 and 6 situated at this region did not express any new mutations for schizophrenia. Taken together these results indicate that the genes HIST1H2BJ, PRSS16, and PGBD1 were not associated with Japanese patients with schizophrenia.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22488895     DOI: 10.1002/ajmg.b.32049

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  5 in total

1.  Reliability of the nanopheres-DNA immunization technology to produce polyclonal antibodies directed against human neogenic proteins.

Authors:  Ahmed Arnaoty; Valérie Gouilleux-Gruart; Sophie Casteret; Bruno Pitard; Yves Bigot; Thierry Lecomte
Journal:  Mol Genet Genomics       Date:  2013-06-07       Impact factor: 3.291

2.  No Associations Found between PGBD1 and the Age of Onset in Japanese Patients Diagnosed with Sporadic Alzheimer's Disease.

Authors:  Tohru Ohnuma; Tohru Nakamura; Yuto Takebayashi; Ryo Hanzawa; Maiko Kitazawa; Ryoko Higashiyama; Mayu Takeda; Katrin Thompson; Miwa Komatsu; Hiromi Shimazaki; Nobuto Shibata; Heii Arai
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2012-11-10

3.  Replication of association between schizophrenia and chromosome 6p21-6p22.1 polymorphisms in Chinese Han population.

Authors:  Yang Zhang; Tianlan Lu; Hao Yan; Yanyan Ruan; Lifang Wang; Dai Zhang; Weihua Yue; Lin Lu
Journal:  PLoS One       Date:  2013-02-21       Impact factor: 3.240

4.  Schizophrenia‑associated microRNA‑148b‑3p regulates COMT and PRSS16 expression by targeting the ZNF804A gene in human neuroblastoma cells.

Authors:  Shanshan Wu; Pengjie Wang; Ran Tao; Pengbo Yang; Xiaorui Yu; Ye Li; Qiuya Shao; Fayi Nie; Jing Ha; Rui Zhang; Ye Tian; Jie Ma
Journal:  Mol Med Rep       Date:  2020-06-15       Impact factor: 2.952

5.  A Novel Gene Controls a New Structure: PiggyBac Transposable Element-Derived 1, Unique to Mammals, Controls Mammal-Specific Neuronal Paraspeckles.

Authors:  Tamás Raskó; Amit Pande; Kathrin Radscheit; Annika Zink; Manvendra Singh; Christian Sommer; Gerda Wachtl; Orsolya Kolacsek; Gizem Inak; Attila Szvetnik; Spyros Petrakis; Mario Bunse; Vikas Bansal; Matthias Selbach; Tamás I Orbán; Alessandro Prigione; Laurence D Hurst; Zsuzsanna Izsvák
Journal:  Mol Biol Evol       Date:  2022-10-07       Impact factor: 8.800

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.